Rapid Micro Biosystems (RPID) Revenue (2020 - 2026)

Rapid Micro Biosystems has disclosed Revenue across 7 years of filings, most recently posting $8.1 million for Q2 2026.

• In Q2 2026, Revenue rose 10.91% year-over-year to $8.1 million; the TTM figure through Jun 2026 stood at $35.2 million (up 16.13% YoY), while the FY2025 annual figure was $33.6 million, up 19.74% from the prior year.
• Revenue came in at $8.1 million for Q2 2026 at Rapid Micro Biosystems, up from $8.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $11.3 million in Q4 2025 to a low of $3.9 million in Q2 2022.
• Average Revenue over 5 years is $6.5 million, with a median of $6.5 million recorded in 2023.
• Year-over-year, Revenue plunged 37.03% in 2022 and soared 44.88% in 2023.
• Over 5 years, Revenue stood at $4.4 million in 2022, then surged by 44.88% to $6.3 million in 2023, then grew by 29.68% to $8.2 million in 2024, then surged by 37.28% to $11.3 million in 2025, then dropped by 28.61% to $8.1 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $8.1 million in Q2 2026, $8.0 million in Q1 2026, and $11.3 million in Q4 2025.